Zynerba Pharmaceuticals OverviewZynerba Pharmaceuticals Net Income
Profitability analysis for ZYNE.
Quarterly Net Income
-$10.78M
↓ 2.27% YoY
As of Jun 2023
Annual Net Income (TTM)
-$37.01M
↑ 3.69% YoY
Trailing 12 months ending Jun 2023
Average Net Income (Comparison Companies)
Net Income History
Net Income Comparison
Annual Net Income Growth Rate (%)
Loading...
Annual Net Income Growth (Absolute)
Loading...